12/05/2019
More than two dozen scientists at the AMP 2019 Annual Meeting and Expo presented research featuring Droplet Digital PCR (ddPCR). Included were studies validating ddPCR Assays for predicting and monitoring treatment
11/10/2019
EveryBlot Blocking Buffer, a western blot blocking reagent that offers 5-minute blocking time and produces higher signal to lower background levels resulting in greater sensitivity for all detection methods.
11/07/2019
Bio-Rad will demonstrate the new QX ONE platform to a select group of customers as part of early-access launch.
10/15/2019
Scientists will present 24 abstracts that used Bio-Rad’s droplet-based technologies to advance translational genetics research, including a study mapping epigenetic variations in the brain at single-cell resolution.
09/20/2019
Bio-Rad announces that it has joined the European Molecular Biology Laboratory (EMBL) Corporate Partnership Programme, to help expand EMBL’s innovative portfolio of scientific training courses designed for budding young
09/18/2019
New to Bio-Rad's Explorer Program, the Science of Opioid Dependence Kit is an entry-level bridge between DNA electrophoresis & PCR — a new way of teaching genetics in the context of a current crisis: the opioid crisis.
07/14/2019
The Multiplex Panel Covers Biologically-Researched Cytokine Targets Associated with Immunotherapy Research
07/11/2019
Bio-Rad’s Reliance One-Step Multiplex Supermix is a highly sensitive and robust reagent mix for detection and quantification of up to five RNA or DNA targets in one reaction.
07/10/2019
Scientists at the 2019 ASCO Annual Meeting presented research that relied on Droplet Digital PCR to explore the strengths and limitations of using circulating tumor DNA as a biomarker for predicting outcomes and guiding
06/25/2019
Nature Biotechnology recently published joint research from Bio-Rad and Harvard featuring Bio-Rad’s new single-cell ATAC-Seq solution.